Application of the nonlinear Blinder-Oaxaca decomposition to study racial/ethnic disparities in antiobesity medication use in the United States

Research in Social and Administrative Pharmacy

Volumn 9, Issue 1, 2013, Pages 13-26

  Mehta, Hemalkumar B ^a   Rajan, Suja S ^b   Aparasu, Rajender R ^a   Johnson, Michael L ^a  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Antiobesity medications; Nonlinear Blinder Oaxaca decomposition; Obesity; Racial ethnic disparity

Indexed keywords

ANTIOBESITY AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE SURVEY; HEALTH SERVICE; HISPANIC; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONLINEAR SYSTEM; OBESITY; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; AFRICAN AMERICANS; ANTI-OBESITY AGENTS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES NEEDS AND DEMAND; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONLINEAR DYNAMICS; OBESITY; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84872391733     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2012.02.006     Document Type: Article

References (38)

1. Institute of Medicine Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care 2002, National Academies Press, Washington, DC.
2. United States Department of Health and Human Services Healthy People 2010: Understanding and Improving Health 2000, U.SDepartment of Health and Human Services, Washington, DC.
3. Keppel K., Garcia T., Hallquist S., Ryskulova A., Agress LComparing racial and ethnic populations based on Healthy People 2010 objectivesHealthy People Stat Notes 2008, 26:1-16.
4. Keppel K.G., Pearcy J.NHealthy people 2010: measuring disparities in healthChance 2009, 22(1):6-9.
5. Keppel K.G., Pearcy J.N., Heron M.PIs there progress toward eliminating racial/ethnic disparities in the leading causes of death?Public Health Rep 2010, 125(5):689-697.
6. Hall-Lipsy E.A., Chisholm-Burns M.APharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatmentAm J Health Syst Pharm 2010, 67(6):462.
7. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.RPrevalence and trends in obesity among US adults, 1999-2008JAMA 2010, 303(3):235.
8. Low S., Chin M.C., Deurenberg-Yap MReview on epidemic of obesityAnn Acad Med Singap 2009, 38(1):57-59.
9. Wang Y., Beydoun M., Liang L., Caballero B., Kumanyika SWill all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemicObesity 2008, 16(10):2323-2330.
10. Centers for Disease Control and Prevention (CDC) Differences in prevalence of obesity among black, white, and Hispanic adults - United States, 2006-2008MMWR Morb Mortal Wkly Rep 2009, 58(27):740-744.
11. Khan L.K., Serdula M.K., Bowman B.A., Williamson D.FUse of prescription weight loss pills among U.Sadults in 1996-1998Ann Intern Med 2001, 134(4):282-286.
12. Cawley J., Rizzo J.AOne pill makes you smaller: the demand for anti-obesity drugsAdv Health Econ Health Serv Res 2007, 17:149-183.
13. Tsai A.G., Wadden T.A., Pillitteri J.L., et alDisparities by ethnicity and socioeconomic status in the use of weight loss treatmentsJ Natl Med Assoc 2009, 101(1):62-70.
14. Blinder A.SWage discrimination: reduced form and structural estimatesJ Hum Resource 1973, 8(4):436-455.
15. Oaxaca RMale-female wage differentials in urban labor marketsInt Econ Rev 1973, 14(3):693-709.
16. Fairlie RAn extension of the Blinder-Oaxaca decomposition technique to logit and probit modelsJ Econ Soc Meas 2005, 30(4):305-316.
17. Chen J., Rizzo J.ARacial and ethnic disparities in antidepressant drug useJ Ment Health Policy Econ 2008, 11(4):155-165.
18. Chen J., Fang H., Vargas-Bustamante A., Rizzo J.A., Ortega A.NLatino disparities in prescription drug use and expenditures: a nationally representative analysisAnn Pharmacother 2010, 44(1):57-69.
19. Mortensen K., Song P.HMinding the gap: a decomposition of emergency department use by Medicaid enrollees and the uninsuredMed Care 2008, 46(10):1099-1107.
20. Bustamante A.V., Fang H., Rizzo J.A., Ortega A.NHeterogeneity in health insurance coverage among US Latino adultsJ Gen Intern Med 2009, 24(suppl 3):561-566.
21. Kirby J.B., Taliaferro G., Zuvekas S.HExplaining racial and ethnic disparities in health careMed Care 2006, 44(5 suppl):I64-I72.
22. Dutton D.J., McLaren LExplained and unexplained regional variation in Canadian obesity prevalenceObesity 2011, 19(7):1460-1468.
23. Garcia-Altes A., Pinilla J., Ortun VThe evolution of health status and chronic conditions in Catalonia, 1994-2006: the paradox of health revisited using the Blinder-Oaxaca decompositionBMC Health Serv Res 2011, 11:116.
24. Stewart Williams JA Using non-linear decomposition to explain the discriminatory effects of male-female differentials in access to care: a cardiac rehabilitation case studySoc Sci Med 2009, 69(7):1072-1079.
25. Emamian M.H., Zeraati H., Majdzadeh R., Shariati M., Hashemi H., Fotouhi AThe gap of visual impairment between economic groups in Shahroud, Iran: a Blinder-Oaxaca decompositionAm J Epidemiol 2011, 173(12):1463-1467.
26. Bauer T., Sinning MAn extension of the Blinder-Oaxaca decomposition to nonlinear modelsAStA Adv Stat Anal 2008, 92(2):197-206.
27. Wang J., Mullins C.D., Zuckerman I.H., et alMedical Expenditure Panel Survey: a valuable database for studying racial and ethnic disparities in prescription drug useRes Social Adm Pharm 2008, 4(3):206-217.
28. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adultsArch Intern Med 1998, 1589(17):1855-1867.
29. National Institute of Health; National Heart, Lung and Blood Institute (NHLBI) Obesity Education Initiative Expert Panel on the Identification Evaluation and Treatment of Overweight and Obesity in AdultsThe practical guide: identification, evaluation, and treatment of overweight and obesity in adultsBethesda, MD: NIH 2000NIH Publication Number 00-4084.
30. Andersen R.MRevisiting the behavioral model and access to medical care: does it matter?J Health Soc Behav 1995, 36(1):1-10.
31. Evaluation of the Counterweight Programme for obesity management in primary care: a starting point for continuous improvementBr J Gen Pract 2008, 58(553):548-554Counterweight Project Team.
32. Anderson L.A., Eyler A.A., Galuska D.A., Brown D.R., Brownson R.CRelationship of satisfaction with body size and trying to lose weight in a national survey of overweight and obese women aged 40 and older, United StatesPrev Med 2002, 35(4):390-396.
33. Blanck H.M., Khan L.K., Serdula M.KUse of nonprescription weight loss products: results from a multistate surveyJAMA 2001, 286(8):930-935.
34. Blanck H.M., Serdula M.K., Gillespie C., et alUse of nonprescription dietary supplements for weight loss is common among AmericansJ Am Diet Assoc 2007, 107(3):441-447.
35. Elliott R.A., Ross-Degnan D., Adams A.S., Safran D.G., Soumerai S.BStrategies for coping in a complex world: adherence behavior among older adults with chronic illnessJ Gen Intern Med 2007, 22(6):805-810.
36. Pokras S.M., Klingman D., Tierce J.CFactors associated with prescription of obesity medications in the USPharmacoepidemiol Drug Saf 2008, 17(suppl 1):S143(abstract 326).
37. Hendricks E.J., Rothman R.B., Greenway F.LHow physician obesity specialists use drugs to treat obesityObesity 2009, 17(9):1730-1735.
38. Bleich S.N., Pickett-Blakely O., Cooper L.APhysician practice patterns of obesity diagnosis and weight-related counselingPatient Educ Couns 2011, 82(1):123-129.